Stimcell Energetics Inc. (STME) stock
Close on Oct 19, 2026Market cap $3.42MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Aug 31, 2026
Valuation
- Market cap
- $3.42M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 21M
Trading
- Previous close
- $0.23
- Open
- $0.20
- Day's range
- $0.16 – $0.20
- Volume
- 867
- Average volume (20 days)
- 2,890
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | STME | S&P 500 | Difference | STME per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -26.4% | +0.6% | −27.0 pts | ||
| 3 months | -41.3% | +3.4% | −44.7 pts | ||
| Year to date | -59.5% | +13.3% | −72.8 pts | ||
| 1 year | -64.0% | +16.6% | −80.6 pts | ||
| 3 years | +794.9% | +86.4% | +708.5 pts | +107.6% | +23.1% |
| 5 years | -14.7% | +81.9% | −96.6 pts | -3.1% | +12.7% |
| 10 years | -37.7% | +318.9% | −356.6 pts | -4.6% | +15.4% |
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
Gross profit
Net income
EPS, diluted
Free cash flow
Press releases
Releases Stimcell Energetics filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
About Stimcell Energetics
Surgical & Medical Instruments & Apparatus
Stimcell Energetics Inc. is a biotechnology company dedicated to the research, development, and commercialization of therapeutic and wellness products based on microcurrent technology. Its core proprietary offering is eBalance Technology, designed to deliver bioelectric micro amperage current to support cellular function, assist in general wellness, relieve pain, and help manage complications related to diseases such as diabetes, neuropathy, and high blood pressure. The company develops hardware solutions including the eBalance Pro System, intended for healthcare practitioners in clinical settings, and the eBalance Home System, engineered for direct in-home use by patients.
Company profile, executives and historyStimcell Energetics stock: common questions
What is Stimcell Energetics's stock price?
STME closed at $0.16 on Oct 19, 2026, down 29.57% on the day.
What is Stimcell Energetics's market cap?
Stimcell Energetics was worth $3.42M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
Does Stimcell Energetics pay a dividend?
No. Stimcell Energetics has not paid a cash dividend over the last twelve months.
How has STME stock performed over the past year?
Including dividends, STME returned -64.0% over the past year, against +16.6% for the S&P 500.
Who are Stimcell Energetics's competitors?
Companies most similar to Stimcell Energetics by business, industry and size include EMED, BTCY, NUMD, TCMD, AMIX.
See a number that looks wrong?